proved by the institutional review board of the National Center for AIDS/STD Control and Prevention at the Chinese Center for Disease Control and Prevention. This study was exempt from informed consent procedures, because it is a secondary analysis of existing program data. (Parents and guardians of minor patients entering the National Pediatric ART Program sign informed consents at time of enrollment.) Table 1 Infants included in our cohort were reported to CRIMS between January 1, 2011, and December 31, 2015, and were younger than 2 years at CRIMS entry. The study endpoint was March 31, 2016. Primary outcomes were the time from birth to CRIMS reporting, the time from CRIMS reporting to initiation of ART, and all-cause mortality. Secondary outcomes were the determinants of ART initiation and determinants of death; these were assessed by Cox proportional hazards regression. All analyses were performed with R statistical package, version 3.3.0 (R Development Core Team).
Results | The cohort included 689 infants. Most were of the Han Chinese ethnicity (n = 427; 62.0%), and most were residents of rural areas (n = 629; 91.3%) ( Table 1) . The overall median time from birth to CRIMS reporting was 601 days (interquartile range [IQR] , 556-659), which decreased by 59.5 days from 2011 to 2015 (median, 630; IQR, 585-679, in 2011; and median, 570.5; IQR, 232-640, in 2015) . A total of 390 infants (56.6%) began ART during the study. Overall median time from CRIMS reporting to ART initiation was 133 days (IQR, 29-352), which decreased by 333 days from 2011 to 2015 (median, 378; IQR, 133-704 in 2011; median, 45; IQR, 17-113 in 2015) . We found increased odds of ART initiation for those with Han ethnicity (adjusted hazard ratio [aHR], 1.48; 95% CI, 1.20-1.83) and CRIMS entry between 2012 and 2015 (aHR, 1.41; 95% CI, 1.11-1.81), and decreased odds for rural residents (aHR, 0.70; 95% CI, 0.49-0.99) and those with missing CD4 counts (aHR, 0.12; 95% CI, 0.07-0.20). Overall all-cause mortality was 15.2%, but this was substantially lower among treated infants (4.9%) vs untreated infants (28.8%). Use of ART was protective (aHR, 0.24; 95% CI, 0.14-0.41), as was CRIMS entry between 2012 and 2015 (aHR, 0.59; 95% CI, 0.37-0.93), while low CD4 count (aHR, 3.97; 95% CI, 2.01-7.85) and unknown CD4 count (aHR, 12.70; 95% CI, 6.39-25.22) were risk factors for death ( Table 2) . Discussion | We found a large and persistent delay in CRIMS entry. Since starting ART depends on information in CRIMS, entry into the system is the most crucial stage for Chinese infants. However, CRIMS reporting is dependent on diagnosis, and although exposed infants should receive early infant diagnosis (EID) via virological testing at age 6 weeks, 4,5 a recent systematic review 3 found that EID was not implemented nationwide in China. Rather, two-thirds of exposed infants received serological HIV testing at age 18 months, and onethird died or were lost to follow-up. We suspect that local Chinese health care workers do not carry out timely virological tests, but rather delay the testing and reporting of HIVexposed infants until after maternal antibodies no longer interfere with serological tests.
6
For infants who received ART, the median time from CRIMS reporting to ART initiation decreased substantially from 378 days in 2011 to 45 days in 2015. The initiation of ART was more likely for Han Chinese and less likely for rural residents, reflecting the continued influence of societal imbalances. As expected, ART was protective against death, while low and unknown CD4 counts were risk factors. Decreased risk of death among in- fants reported to CRIMS from 2012 to 2015 suggests a positive effect of the new policy of immediate ART initiation. This study was limited to the information available in CRIMS, and there was potential for bias related to infant death and loss to follow-up prior to entry into CRIMS as well as unequal observed time for participants. However, we provide evidence of a long delay in CRIMS reporting was associated with profoundly reduced effect on survival. Policymakers should consider integrating follow-up, EID, and ART initiation into prevention of mother-to-child transmission programs to address programming gaps and serious flaws in HIV service delivery.
